NEJM Interview: Dr. Allison Goldfine on statins, the associated risk of diabetes, and the FDA's response.

NEJM Interviews - Podcast autorstwa NEJM Group - Środy

Podcast artwork

Dr. Allison Goldfine is the head of the Section of Clinical Research at Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A.B. Goldfine. Statins: Is It Really Time to Reassess Benefits and Risks? N Engl J Med 2012;366:1752-5.

Visit the podcast's native language site